Insight

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Insight

Measurable residual disease monitoring in AML

Photo of Nicholas J. Short taken from mskcc.org

Oct 1, 2024, 15:57

Measurable residual disease monitoring in AML

Top Biomedical Science shared on X:

“Measurable residual disease monitoring in AML:

Prospects for therapeutic decision-making and new drug development.”

Source: Top Biomedical Science/X

Measurable residual disease monitoring in AML: Prospects for therapeutic decision-making and new drug development

Authors: Nicholas J. Short, Richard Dillon

disease

AML cancer drug development leukaemia Nicholas J. Short OncoDaily Oncology residual disease monitoring Richard Dillon Top Biomedical Science

Oct 1, 2024, 15:57

Measurable residual disease monitoring in AML

Oct 1, 2024, 15:51

Kimryn Rathmell: The many ways National Cancer Institute is making a difference in childhood cancer

Oct 1, 2024, 15:50

Anirban Maitra: Do multiple tumor promoting pathways converge on a common family of kinases?

Oct 1, 2024, 15:46

Résilience et rétablissement: le combat de Guitta Chartouni contre le cancer de l'ovaire de stade 4

Oct 1, 2024, 15:46

Stephen Liu: It’s my first ASTRO

Oct 1, 2024, 15:39

Erman Akkus: Would you recommend adjuvant treatment for stage II endometrioid type endometrial carcinoma

Oct 1, 2024, 15:36

PROTECT EUROPE Masterclasses about communication for HPV elimination - ECO

Oct 1, 2024, 15:32

Mukhtasar Alkali: A vital discussion on "Equitable Cancer Care for all across the MENA Region"

Oct 1, 2024, 15:27

Oncoinfluencers to Follow on Social Media: Dr. Pamela Kunz

Oct 1, 2024, 15:27

Stephen V Liu: Eager to join the 6th International Lung Cancer Summit

Oct 1, 2024, 15:19

Another fruitful EORTC Quality of Life Group meeting

Oct 1, 2024, 15:05

World Child Cancer: Influence policy and public opinion on childhood cancer